The article is structured so a reader can move from a baseline definition to mechanism, then to the trial data, then to a like-for-like comparison with tirzepatide and semaglutide, and finally to the regulatory and laboratory-handling questions that researchers most often ask
Nicholls SJ, Bhatt DL, Buse JB, Del Prato S, Kahn SE, Lincoff AM, et al
Malhotra points out that studies have repeatedly shown CPAP fails to improve cardiovascular morbidity and mortality, so treating the underlying cause of the sleep apnea might be required to really see the benefits. Malhotra says, Everything went in the right direction
Although GLP-1s have only been FDA-approved within the last two decades, the science behind them dates back to the 1960s, when researchers discovered a family of hormones called incretins
Always swirl, never shake
By acting on both GLP-1 and GIP receptors, tirzepatide offers an even more potent effect on appetite suppression and blood sugar regulation, often resulting in greater weight loss compared to semaglutide in clinical trials